Avalyn Pharma has filed a notice of an exempt offering of securities to raise $189,182,622.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Avalyn Pharma is raising $189,182,622.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Lyn Baranowski played a key role…